Since starting escitalopram (Lexapro), the patient reports teeth clenching (bruxism) and jaw pain; how should this be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Lexapro-Induced Bruxism and Jaw Pain

The first-line approach is to add buspirone 5 mg daily, which typically resolves SSRI-induced bruxism within 3-4 weeks while allowing continuation of Lexapro for the underlying psychiatric condition.

Understanding the Problem

Bruxism (teeth clenching and grinding) with jaw pain is a recognized adverse effect of escitalopram (Lexapro) and other SSRIs, though it's not prominently listed in the FDA label 1. This occurs through serotonergic-mediated inhibition of dopamine, manifesting as a form of akathisia or movement disorder 2, 3. The phenomenon typically begins within 3-4 weeks of medication initiation and can occur at any dose 3.

Immediate Management Algorithm

Step 1: Confirm the Diagnosis

  • Temporal relationship: Symptoms started after Lexapro initiation (typically within 3-4 weeks) 3
  • Clinical features: Daytime jaw clenching, teeth grinding, jaw pain/tenderness 2
  • Dental referral: Rule out primary dental pathology (TMJ inflammation, occlusal abnormalities) - though these are unlikely if symptoms coincided with medication start 2

Step 2: Choose Your Management Strategy

Option A: Add Buspirone (Preferred)

  • Start buspirone 5 mg once daily (can give at bedtime if bruxism is nocturnal) 2, 4, 5
  • Mechanism: 5-HT1A agonist that reduces serotonergic activity and increases dopaminergic activity 4
  • Expected timeline: Significant improvement within 4 days to 4 weeks 2, 5
  • Advantage: Maintains psychiatric benefit of Lexapro while resolving bruxism
  • This approach is supported by multiple case reports showing consistent efficacy 2, 4, 5

Option B: Switch Antidepressants

  • If buspirone fails or is not tolerated, consider switching to a non-SSRI antidepressant
  • Venlafaxine (SNRI) may still cause mild bruxism 2
  • Important caveat: Don't abruptly stop Lexapro - taper appropriately to avoid discontinuation syndrome

Option C: Dose Reduction

  • May reduce severity but often doesn't fully resolve symptoms 3
  • Risks losing psychiatric efficacy
  • Less preferred than buspirone augmentation

Option D: Discontinue Lexapro

  • Expected timeline: Symptoms typically resolve within 3-4 weeks of discontinuation 3
  • Only if psychiatric condition allows or alternative treatment is immediately available
  • Must weigh against risk of depression/anxiety relapse

What NOT to Do

Avoid occlusal splints/mouthguards as primary treatment - While TMD guidelines recommend bite plates for primary bruxism 6, these are conditionally recommended AGAINST for chronic TMD pain 6 and don't address the underlying medication-induced mechanism. A mouthguard may protect teeth from damage but won't resolve the drug-induced movement disorder 2.

Additional Considerations

If Bruxism Persists Despite Buspirone

  • Reassess the diagnosis - is this truly medication-induced or a separate TMD issue?
  • Consider pharmacogenetic testing (CYP2C19, CYP2D6) if available - certain metabolizer phenotypes may predispose to SSRI-induced movement disorders 2
  • Refer to dentistry for conservative TMD management if symptoms persist: jaw exercises, heat/cold application, NSAIDs for pain 6

Monitoring

  • Follow up within 2-4 weeks after starting buspirone
  • Ask specifically about jaw pain, tooth grinding, and jaw clenching (patients may not volunteer this information) 3
  • Document improvement or lack thereof to guide next steps

Clinical Pearls

  • Bruxism is underrecognized: The FDA label doesn't prominently feature bruxism, and the true incidence is unknown because patients and physicians may be reluctant to discuss it 1, 3
  • Screen proactively: Ask about jaw symptoms during early SSRI titration, especially in the first month 2, 3
  • Gender consideration: More commonly reported in female patients 3
  • Buspirone works quickly: Most patients report significant improvement within days, not weeks 5
  • Don't confuse with primary TMD: The temporal relationship with medication start is key - primary TMD wouldn't suddenly appear coincident with Lexapro initiation

References

Research

Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 2009

Research

Possible paroxetine-induced bruxism.

The Annals of pharmacotherapy, 1996

Related Questions

In a patient with anxiety treated with Adderall (amphetamine/dextroamphetamine) and sertraline, who develops new bruising, which medication should be adjusted?
In a patient with major depressive disorder and anxiety who started sertraline (Zoloft) 25 mg one week ago and now has new‑onset jaw clenching (bruxism), how should this adverse effect be managed?
Can bruxism be a side effect of ramelteon or seroquel (quetiapine)?
Can venlafaxine extended-release cause bruxism (teeth grinding)?
If a patient develops bruxism while taking sertraline, is it likely to occur with any selective serotonin reuptake inhibitor (SSRI)?
What amount of packed red blood cells should be transfused in a 9‑kg child with a hemoglobin of 4.8 g/dL?
What is the appropriate gentamicin dose for a 178‑lb (≈81 kg) adult female?
Which of the following statements about systemic lupus erythematosus nephropathy are correct: (a) the histological class may change over the disease course, (b) anti‑double‑stranded DNA antibodies are used to monitor progression, (c) survival of SLE patients on hemodialysis is lower than that of patients with other primary renal diseases, (d) renal involvement at diagnosis occurs in only 10 % of cases, (e) its prevalence does not differ between sexes?
What are the clinical features and etiological spectrum of pediatric hypertension in a tertiary care setting in [State]?
What is the recommended workup and treatment plan for a patient over 65 years old with suspected dementia?
What is the recommended dosage for the SOX regimen (S‑1 plus oxaliplatin)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.